谷歌浏览器插件
订阅小程序
在清言上使用

Abstract P1-01-02: Circulating Tumor Cells (CTC) and Endothelial Cells (CEC) Prognostic Value in HER2 Negative Metastatic Breast Cancer Patients Treated with First Line Weekly Paclitaxel and Bevacizumab: First Results of a Prospective Cohort from the French Breast Cancer InterGroup Unicancer (UCBG): COMET Study

Cancer Research(2017)

引用 0|浏览7
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要